Switzerland · 
Who invested in metaLead Therapeutics?
metaLead Therapeutics's investors include UZH Life Sciences Fund, Venture Kick and BioInnovation Institute. UZH Life Sciences Fund led its latest round.
Switzerland · Seed startup
Who invested in metaLead Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$1.2Mraised across 1 round since 2025, from 2 sources
- Latest round
- Seed, $1.2MMay 2025
- Led by
- UZH Life Sciences Fund
- Investors
- 3 (1 led)
The rounds
- May 2025Seed$1.2M
Reported by Firms' own news pages and 1 other
Everyone who backed them
BioInnovation InstituteVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about metaLead Therapeutics
How much has metaLead Therapeutics raised?
metaLead Therapeutics has raised $1.2M across 1 round since 2025.
When did metaLead Therapeutics last raise?
metaLead Therapeutics's most recent round was a Seed of $1.2M in May 2025, led by UZH Life Sciences Fund.
What was metaLead Therapeutics's biggest round?
Its most recent round, $1.2M in May 2025, is also its largest on record.
Who backed metaLead Therapeutics first?
metaLead Therapeutics's first round on record, in May 2025, was backed by UZH Life Sciences Fund, Venture Kick and BioInnovation Institute.
What stage is metaLead Therapeutics at?
metaLead Therapeutics's latest named round is a Seed, in May 2025.
Where is metaLead Therapeutics based?
metaLead Therapeutics is based in Switzerland.
Who led metaLead Therapeutics's rounds?
UZH Life Sciences Fund led the Seed in 2025.
Companies like metaLead Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.